CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹158 Cr | ₹149 Cr | ₹129 Cr | ₹102 Cr | ₹100 Cr |
What is the latest Long Term Provisions ratio of CIPLA ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹158 Cr |
| Mar2025 | ₹149 Cr |
| Mar2024 | ₹129 Cr |
| Mar2023 | ₹102 Cr |
| Mar2022 | ₹100 Cr |
How is Long Term Provisions of CIPLA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹158 Cr | 5.97 | |
| Mar2025 | ₹149 Cr | 15.03 | |
| Mar2024 | ₹129 Cr | 26.53 | |
| Mar2023 | ₹102 Cr | 1.94 | |
| Mar2022 | ₹100 Cr | - | |
Compare Long Term Provisions of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹115,648.7 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
| MANKIND PHARMA | ₹102,795.0 Cr | 0.1% | 5.5% | 10.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.7% |
3.1% |
-4.2% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses